Cenforce-D

Cenforce-D is a combination oral medication that contains two active pharmaceutical ingredients: Sildenafil Citrate (100 mg) and Duloxetine Hydrochloride (60 mg). It is classified as a fixed-dose combination product intended for the concurrent management of two distinct but often comorbid conditions: erectile dysfunction (ED) and premature ejaculation (PE). This monograph provides an evidence-based analysis of its pharmacology, clinical applications, safety profile, and practical prescribing considerations. The information presented is derived from peer-reviewed literature, regulatory databases, and clinical experience.